Introduction
one of the genes that gained much attention as a possible marker for tumour hypoxia in vivo [17] . CA-IX protein expression also correlates with poor prognosis in solid tumours [18, 19] . Interestingly, CA-IX protein is expressed only in a fraction of CRC hypoxic cells, suggesting that micro-environmental factors, other than hypoxia, up-regulate in vivo CA-IX expression [20] . In fact, CA-IX gene expression is induced by hypoxia-independent mechanisms, such as the activation of ERK pathway [21] [22] [23] . Notably, ERK1/2 pathway activation is triggered by COX-2/PGE2 axis up-regulation [24] . We here sought to investigate the interplay between COX-2 and CA-IX genes in CRC cells and we explored the correlation between the expression of COX-2 and CA-IX proteins in CRC tissues. 
Methods

Cell culture
Human colon cancer cells HT-29, HCT-116, HCA-7 and Caco-2 were obtained from American Type Culture Collection (Manassas, VA, USA), cultured at 37ЊC in 5% CO2 in Dulbecco's modified Eagle's medium (DMEM, Cambrex Bio Science, Bergamo, Italy) supplemented with 10% heat-inactivated foetal calf serum (FCS). Hypoxia culture condition (2% O2
)
COX-2 specific short hairpin RNA (shRNA)
Constructs coding for anti-COX-2 shRNA were prepared as described elsewhere [25] . Forward Table S1 ). Fig. 2A) . Notably, no cell death was observed in such experimental conditions (see Fig. 2A ). [33, 34] , we hypothesized that CA-IX may control the activation of MMPs [35, 36] . 
Cell invasion assay and gelatin zymography
RNA extraction and RT-PCR analysis
Results
COX-2 expression and PGE 2 production promote an ERK-dependent CA-IX up-regulation
This investigation started with the observation that high COX-2 expression level is accompanied by the up-regulation of CA-IX protein in colorectal cell lines (Fig. 1A). We therefore sought to investigate the functional relationship between COX-2 and CA-IX gene expression. We purposely examined HT-29 cells sub-population infected with a pSUPER.retro vector, encoding a COX-2 specific (shCOX-2) or control (shCTR) short hairpin RNA. RT-PCR and Western blot (WB) analyses revealed that shCOX-2 HT-29 infected cells showed reduced levels of CA-IX mRNA and protein compared to shCTR infected cells (Fig. 1B). Given that CA-IX gene is regulated by two molecular pathways, namely HIF-1␣ [30] and MAP kinase ERK1/2 [21-23], we then evaluated the protein levels of HIF-1␣, ERK1/2 and phosphorylated ERK1/2 (pERK) in shCTR/COX-2 HT-29 infected cells. We found lower amounts of pERK protein in shCOX-2 HT-29 infected cells compared to shCTR HT-29 infected ones, whereas no HIF-1␣ expression was found in such a culture condition (Fig. 1C). Moreover, due to the capability of COX-2 and PGE2 activate ERK pathway, we tested the role of ERK1/2 protein in COX-2/CA-IX interplay. We found that the PGE2-dependent up-regulation of CA-IX gene was halted by the administration of the MEK1/ERK inhibitor UO-126 (Fig. 1D). The PGE2/ERK-dependent regulation of CA-IX gene expression was then evaluated by CA-IX gene promoter activity assay (CA-IX Luc) in HT-29 cells. We observed a lower level of CA-IX Luc activity in shCOX-2 HT-29 infected compared to shCTR infected cells, and we found that PGE2 administration triggered an ERK-dependent increase of CA-IX Luc activity (Fig. 1E
Due to the strict connection between COX-2 and metalloproteinases (MMPs) expression and activity
Western blot analysis revealed lower levels of extracellular/active, but not intracellular/inactive, MMP-2 protein level in shCOX-2 HT-29 infected cells and in CA-IX siRNA HT-29 transfected cells
Fig. 1 COX-2 up-regulates CA-IX gene expression. (A) Western blot (WB) analysis of CA-IX and COX-2 protein level in 4 colon cancer cell lines: HCT-116, HT-29, Caco-2 and HCA-7. (B) HT-29 cells, stably infected with a pSUPER.retro vector encoding a COX-2 specific (shCOX-2) or control (shCTR) short hairpin RNA: RT-PCR analysis of CA-IX and COX-2 mRNA level, WB analysis of CA-IX, COX-2 and ␤-Actin. (C) WB analysis of phosphorylated ERK 1/2 (pERK), total ERK and HIF-1␣ protein level in shCTR/COX-2 HT-29 infected cells (␤-Actin is reported in panel B). (D) HT
COX-2 gene expression enhances CA-IX-dependent hypoxia survival
CA-IX is a hypoxia survival gene [17, 23] . Recent data show that COX-2 is up-regulated upon hypoxia exposure [12] . (Fig. 4A) . (Fig. 5A) ϭ 0.307, P ϭ 0.460) (Fig. 5A) . (Figs. 5B, C and S2) . These data indicate that COX-2/CA-IX protein expression in CRC specimens is correlated and increased with tumour stage.
S1). Finally, the administration of the COX-2 specific inhibitor SC-236 down-regulated CA-IX mRNA level and triggered cell death
Fig. 2 COX-2/CA-IX interplay promotes invasive potential of colon cancer cells. (A) Boyden chamber invasion assay (24 hrs), RT-PCR analysis of COX-2 and CA-IX mRNA level and cell death assay (24 hrs) in shCTR/COX-2 HT-29 infected cells and in HT-29 cells transiently transfected with a CA-IX specific or scramble (SCR) siRNA (1 g, 48 hrs pre-exposure). (B) WB analysis of active, extracellular (EXT) and inactive, intracellular (INT) protein levels and zymographic assay of MMP-2 in shCTR/COX-2 HT-29 infected cells and SCR/CA-IX siRNA transiently transfected HT-29 cells (1 g, pre-exposure for 48 hrs). ␤2 was assessed as quantitative control for RT-PCR analysis. ␤-Actin was assessed as quantitative control for WB analysis. Data are expressed as mean Ϯ S.D. of three replicates (n ϭ 3) (ANOVA test, *P ϭ 0.001). in HT-29, HCT-116 and HCA-7 cells exposed to DFX (100 M, 48 hrs) (Fig. 3D). Notably, no cell death was observed in cells treated with SC-236, in absence of DFX (100 M for 48 hrs) (data not shown). These data support the argument that COX-2/CA-IX interplay sustains hypoxia survival in CRC cells.
High-density culture condition up-regulates COX-2/CA-IX interplay
We also observed a cell density-dependent increase of the invasive potential in shCTR, but not in shCOX-2 HT-29 infected cells (Fig. 4B). As expected, the increase in the invasive capacity of HT-29 cells cultured at high density was blocked by CA-IX, but not SCR siRNA transfection (Fig. 4C). In the same culture condition, no cell death was observed in shCOX-2 infected or CA-IX siRNA transfected cells (data not shown). Overall, the data reported show that COX-2/CA-IX interplay is up-regulated and modulates invasive behaviour in mild hypoxic conditions. assessed as quantitative control for WB analysis. Data are expressed as mean Ϯ S.D. of three replicates (n ϭ 3) (ANOVA test, § P Ͻ 0.001, post hoc test adjustment for multiple comparison was applied when required).
Fig. 3 COX-2/CA-IX interplay sustains hypoxia survival in HT-29 cells. (A) shCTR/COX-2 HT-29 infected cells: ELISA assay of PGE2 levels in presence/absence of hypoxic conditions (2% O2); CA-IX Luc assay (24 hrs, Luciferase activity is expressed as a ratio over TK-driven Renilla luciferase activity), RT-PCR analysis of CA-IX, COX-2, c-MET, HO-I, BCRP-I and VEGF mRNA level and WB analysis of HIF-1␣, pERK, ERK, VEGF, CA-IX, COX-2 protein level in Desferoxamine (DFX 100 M, 48 hrs) exposed cells; (B) shCTR/COX-2 HT-29 infected cells in presence/absence of DFX 100 M or cultured for 48 hrs in hypoxic condition (2% O2): Cell death assay, RT-PCR analysis of CA-IX
) density condition for 48 hrs: Boyden chamber invasion assay (24 hrs), RT-PCR analysis of COX-2 and CA-IX mRNA level and WB analysis of CA-IX, COX-2, pERK, total ERK protein level. (B) Boyden chamber invasion assay (24 hrs) of shCTR/COX-2 HT-29 infected cells cultured at low-and high-density condition. (C) HT-29 cells cultured at low-and high-density condition and tran-
WB and IHC analyses revealed an increase of COX-2 and CA-IX protein expression level in stage III-IV CRC compared to stage I-II CRC
Discussion
In this investigation, we show that, in CRC cells, the pro-inflammatory enzyme COX-2 up-regulates the expression of the hypoxia response gene CA-IX, throughout the PGE2-dependent activation of ERK-1/2. In CRC cells, COX-2/CA-IX axis elicits aggressive features (invasive behaviour and hypoxia survival). Such activities have been previously associated to the expression of these genes
in separate experimental models [12, 23] . Here, we provide evidence for the existence of a COX-2/CA-IX axis that promotes malignant behaviour in CRC cells. [12, 21, 22] . Here [36] . Noteworthy, PGE2 production and ERK activation have been previously demonstrated to enhance invasiveness and MMPs activity [31, 32] . We here report that COX-2/CA-IX axis up-regulation increases the activity of MMP-2, an enzyme linked to CRC malignancy [39] .
CA-IX gene expression has been previously shown to be induced by HIF-1␣ transcription factor and ERK activation
CA-IX protein expression is regarded as surrogate marker of hypoxia in vivo [17] . The expression of CA-IX correlates with poor prognosis in several cancers [18, 19] . In CRC tissues, CA-IX gene expression has been previously associated with cell proliferation status [20, 40] COX-2 is a major player of inflammation [6] . Inflammatory molecules play a crucial role in CRC growth and malignancy and inflammatory cells promote an aggressive behaviour in CRC cells [42] [43] [44] [45] . A plenty of CA-IX inhibitors have been synthesized so far [46] . Our data suggest that the pharmacological down-regulation of COX-2/CA-IX axis may be a strategy to counteract the aggressiveness of CRC cells [47] [48] [49] .
In 
